Senate: Committee recommended ought to pass and referred to the committee on Senate Ways and Means
Email me when S 817 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 817. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill requires state‑related health plans, Medicaid managed‑care plans, and private accident, sickness and health‑maintenance contracts to provide epinephrine auto‑injectors to anyone under 18 at no cost. It also limits any deductible, co‑insurance or co‑payment for a two‑pack of injectors for adults to $60. Additionally, it creates a commission to examine the manufacturing and pricing of certain allergy drugs.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 817
3 free questions a day, no accountHearings
- Health Insurance - Mandated BenefitsJoint Committee on Financial Services · Oct 8, 2025
History
- Committee recommended ought to pass and referred to the committee on Senate Ways and Means
- Bill reported favorably by committee and referred to the committee on Health Care Financing
- Hearing scheduled for 10/08/2025 from 10:30 AM-02:30 PM in Gardner Auditorium
- Referred to the committee on Financial Services
- House concurred
Sponsors
- Jacob R. Oliveira · sponsor
- Patrick Joseph Kearney
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 817 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 817 freeOr ask your AI assistant about S 817 directly:
Add to Claude, ChatGPT or Cursor